Hackensack Meridian Children’s Health Pediatric Oncology

Offering cutting-edge treatment protocols and hands-on care from newborns to young adults.

Hackensack Meridian Children’s Health pediatric oncologists are leading cutting-edge clinical research while providing diagnosis and treatment of leukemia, lymphoma, neuroblastoma, bone, brain and kidney tumors, as well as rare tumor types.

Combination Cancer Therapy
Joseph M. Sanzari Children’s Hospital Studies New Combination Therapy to Treat Rare, Aggressive Cancer of the Central Nervous System

Hospital is the only site in New Jersey participating in international clinical trial

Pediatric Fertility Program
Joseph M. Sanzari Children’s Hospital Launches Cryopreservation, New Jersey’s Only Fertility Preservation Program

Program offers hope to young patients who undergo cancer treatment that may affect fertility

CIT Study
Research Studies Impact of Chemotherapy-Induced Thrombocytopenia on Pediatric Cancer Treatment

Complication may require platelet transfusions and treatment modifications

New Hematology-Oncology Specialist Joins Joseph M. Sanzari Children’s Hospital

Dr. Camacho-Bydume brings expertise in treatment of blood cancers in children

New Pediatric Hematology-Oncology Specialist to Join Hospital

Dr. Degliuomini’s clinical and research focus is on the effects of children’s cancer treatment on platelets

Pediatric Oncologist/Hematologist Co-Authors Article Accepted for Publication in Leukemia & Lymphoma

Global working group addresses rare subtype of Hodgkin lymphoma

Critical Side Effect Study to Assess the Combination of Trametinib and Everolimus

Treatment offers hope for most common type of brain tumor in children

Hackensack Meridian Children’s Health K. Hovnanian Children’s Hospital to Provide Pediatric Patients Access to Latest Trials for the Treatment of Cancer

Gains Affiliate Status in the Prestigious Children’s Oncology Group (COG)

PNOC Study
Joseph M. Sanzari Children’s Hospital Offers New Clinical Trial for Children and Young Adults Diagnosed with Aggressive or Recurrent Brain Tumors

Hospital Among Only a Few in the U.S. to Offer Clinical Trial Through Pacific Pediatric Neuro-Oncology Consortium Membership

CDI Laboratory Secures NIH Funding for Thymus Immunotherapy Research

Zakrzewski Lab Aims to Train Immune System to Make Its Own CAR T-Cells

Fertility Preservation Program
Joseph M. Sanzari Children’s Hospital Establishes Fertility Preservation Program for Long-Term Pediatric Cancer Survivors

Program aims to prevent or decrease the late effects of chemotherapy, radiation therapy and surgery

Low Grade Gliomas
Clinical Trial Will Evaluate Combination of Therapies in Pediatric and Young Adult Patients with Recurrent Low Grade Gliomas

Researchers Test Combination Therapy for Common Pediatric Tumors

Adult doctor with pediatric patient
Joseph M. Sanzari Children's Hospital at Hackensack University Medical Center Joins the Pacific Pediatric Neuro-Oncology Consortium (PNOC)

Worldwide Partnership Develops New Therapies for Brain Tumors in Children and Young Adults, Offers Exclusive Clinical Trial Access


Advanced Proton Therapy
Hackensack Meridian Children's Health Joins with ProCure NJ to Offer Advanced Proton Therapy for Cancer

Advanced Radiation Therapy Is Now Available for Patients at Hackensack Meridian Children’s Health

Neurological Exam
Pediatric Cancer Trial of Optune Device at Hackensack Meridian Children’s Health

Phase 1 Clinical Trial Tests TTFields Device When Combined with Chemotherapy for Pediatric Patients with Glioblastoma Multiforme

Nero Oncology Lab Building
Hackensack Meridian Health Opens Pediatric Neuro-Oncology Laboratory at the Center for Discovery & Innovation (CDI)

First Lab of Its Kind in New Jersey to Focus on Pediatric Brain Tumor Research

Dr Scerbo
K. Hovnanian Children’s Hospital First in U.S. Granted Children’s Oncology Group (COG) Affiliate Status

Opens Opportunities for Pediatric Patients to Enroll in the Latest Cancer Treatment Trials

We use cookies to improve your site experience. By using this site,
you agree to our Terms & Conditions. Also, please read our Privacy Policy.
Accept All Cookies